Jubilant Life Sciences receives ANDA approval for Celecoxib Capsules
Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, the generic version of Celebrex of GD Searle, which is used for the treatment of Osteoarthritis and Rheumatoid Arthritis. This is the first approval that the company has received from the US Food and Drug Administration (USFDA) during the current financial year. As on December 31, 2016, Jubilant Life Sciences had a total of 73 ANDAs for Oral Solids filed in the US, of which 49 have been approve.
BHEL inks agreement with IROAF to set-up 2 MW roof top power plant
BHEL has inked an agreement with Indian Railways Organization for Alternate Fuel (IROAF) of Indian Railways for constructing a 2 MW roof top power plant at a record low cost of Rs 3.58 crore per MWp (Megawatt peak) under Government of India’s Incentive Scheme. The plant will be commissioned within next 10 months. It will be set up at Diesel-Loco Modernization Works, Patiala formerly Diesel Component Works, Patiala. This is the first project to be covered under Achievement Linked Incentive / Award Scheme of Ministry of New and Renewable Energy (MNRE) for Government buildings.
For More Updates Click Here - http://www.tradebizzindia.com/freetrial
No comments:
Post a Comment